The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2023 | Improving informed consent for lung cancer clinical trials
Bellinda Kallimanis, PhD, LUNGevity Foundation, Tarpon Springs, FL, discusses recent research in improving informed consent in clinical trials for lung cancer. Interviews with a range of industry partners such as ethicists, stakeholders, regulators and triallists were conducted to gain perspectives on the development of patient pamphlets to provide more information about clinical trial medicines. Whilst no general consensus has been found in the best strategy for the pamphlets, an online survey for caregivers and patients was valuable in demonstrating a common preference for short text and bulleted lists. Dr Kallimanis comments on the current goal to create hypothetical pamphlets for patients and caregivers to review. This interview took place at the 2023 World Conference on Lung Cancer (WCLC) in Singapore, Singapore.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
